|
|
Other Issues: Journal List
|
previous
|
next
|
latest
|
archive
Letter Association between the spread of circulating tumor cells and breast cancer subtypes Xiaowei Qi, Xinhua Yang, Linjun Fan, Yi Zhang, Fan Zhang, and Jun Jiang PMCID: PMC2917023 | Free in PMC on 2010/12/17 | Research Articles High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer Johan Staaf, Göran Jönsson, Markus Ringnér, Johan Vallon-Christersson, Dorthe Grabau, Adalgeir Arason, Haukur Gunnarsson, Bjarni A Agnarsson, Per-Olof Malmström, Oskar Th Johannsson, Niklas Loman, Rosa B Barkardottir, and Åke Borg PMCID: PMC2917012 Cyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study Priya P Gor, H Irene Su, Robert J Gray, Phyllis A Gimotty, Michelle Horn, Richard Aplenc, William P Vaughan, Martin S Tallman, Timothy R Rebbeck, and Angela DeMichele PMCID: PMC2917014 Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells Luisa Paris, Serena Cecchetti, Francesca Spadaro, Laura Abalsamo, Luana Lugini, Maria Elena Pisanu, Egidio Iorio, Pier Giorgio Natali, Carlo Ramoni, and Franca Podo PMCID: PMC2917016 Incorporating tumour pathology information into breast cancer risk prediction algorithms Nasim Mavaddat, Timothy R Rebbeck, Sunil R Lakhani, Douglas F Easton, and Antonis C Antoniou PMCID: PMC2917017 Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors Liat Goldshaid, Efrat Rubinstein, Alexander Brandis, Dadi Segal, Noa Leshem, Ori Brenner, Vyacheslav Kalchenko, Doron Eren, Tamar Yecheskel, Yoseph Salitra, Yoram Salomon, and Avigdor Scherz PMCID: PMC2917020 Breast cancer-specific mutations in CK1ε inhibit Wnt/β-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration Silvie Foldynová-Trantírková, Petra Sekyrová, Kateřina Tmejová, Eva Brumovská, Ondřej Bernatík, Wulf Blankenfeldt, Pavel Krejčí, Alois Kozubík, Tomáš Doležal, Lukáš Trantírek, and Vítězslav Bryja PMCID: PMC2917022 Senescence evasion by MCF-7 human breast tumor-initiating cells Feridoun Karimi-Busheri, Aghdass Rasouli-Nia, John R Mackey, and Michael Weinfeld PMCID: PMC2917024 Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-α and survivin Kathryn E Vanderlaag, Susan Hudak, Laura Bald, Laurence Fayadat-Dilman, Manjiri Sathe, Jeff Grein, and Mary J Janatpour PMCID: PMC2917027 Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women Ada Tosovic, Anne-Greth Bondeson, Lennart Bondeson, Ulla-Britt Ericsson, Johan Malm, and Jonas Manjer PMCID: PMC2917028 Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway Lian Zuo, Wei Li, and Shaojin You PMCID: PMC2917029 Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort Huiyan Ma, Katherine D Henderson, Jane Sullivan-Halley, Lei Duan, Sarah F Marshall, Giske Ursin, Pamela L Horn-Ross, Joan Largent, Dennis M Deapen, James V Lacey, Jr, and Leslie Bernstein PMCID: PMC2917030 Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns Karolina Holm, Cecilia Hegardt, Johan Staaf, Johan Vallon-Christersson, Göran Jönsson, Håkan Olsson, Åke Borg, and Markus Ringnér PMCID: PMC2917031 The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET Michal E Schneider-Kolsky, Stewart Hart, Jane Fox, Peter Midolo, John Stuckey, Michael Hofman, and Vinod Ganju PMCID: PMC2917032 Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development Arusha Oloumi, Mykola Maidan, Frances E Lock, Howard Tearle, Steven McKinney, William J Muller, Samuel AJR Aparicio, and Shoukat Dedhar PMCID: PMC2917033 Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer Karen J Taylor, Andrew H Sims, Liang Liang, Dana Faratian, Morwenna Muir, Graeme Walker, Barbara Kuske, J Michael Dixon, David A Cameron, David J Harrison, and Simon P Langdon PMCID: PMC2917034 Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer Chad J Creighton, Xiaoyong Fu, Bryan T Hennessy, Angelo J Casa, Yiqun Zhang, Ana Maria Gonzalez-Angulo, Ana Lluch, Joe W Gray, Powell H Brown, Susan G Hilsenbeck, C Kent Osborne, Gordon B Mills, Adrian V Lee, and Rachel Schiff PMCID: PMC2917035 RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells Joshua A Bauer, Fei Ye, Clayton B Marshall, Brian D Lehmann, Christopher S Pendleton, Yu Shyr, Carlos L Arteaga, and Jennifer A Pietenpol PMCID: PMC2917036 Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics Göran Jönsson, Johan Staaf, Johan Vallon-Christersson, Markus Ringnér, Karolina Holm, Cecilia Hegardt, Haukur Gunnarsson, Rainer Fagerholm, Carina Strand, Bjarni A Agnarsson, Outi Kilpivaara, Lena Luts, Päivi Heikkilä, Kristiina Aittomäki, Carl Blomqvist, Niklas Loman, Per Malmström, Håkan Olsson, Oskar Th Johannsson, Adalgeir Arason, Heli Nevanlinna, Rosa B Barkardottir, and Åke Borg PMCID: PMC2917037 The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells Hirokuni Ikeda, Naruto Taira, Fumikata Hara, Takeo Fujita, Hiromasa Yamamoto, Junichi Soh, Shinichi Toyooka, Tomohiro Nogami, Tadahiko Shien, Hiroyoshi Doihara, and Shinichiro Miyoshi PMCID: PMC2917038 Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer Cristina Cadenas, Dennis Franckenstein, Marcus Schmidt, Mathias Gehrmann, Matthias Hermes, Bettina Geppert, Wiebke Schormann, Lindsey J Maccoux, Markus Schug, Anika Schumann, Christian Wilhelm, Evgenia Freis, Katja Ickstadt, Jörg Rahnenführer, Jörg I Baumbach, Albert Sickmann, and Jan G Hengstler PMCID: PMC2917039 Reviews Tumour-associated carbohydrate antigens in breast cancer Aurélie Cazet, Sylvain Julien, Marie Bobowski, Joy Burchell, and Philippe Delannoy PMCID: PMC2917018 | Free in PMC on 2010/12/08 | The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis Jessica McCready, Lisa M Arendt, Jenny A Rudnick, and Charlotte Kuperwasser PMCID: PMC2917019 | Free in PMC on 2010/12/17 | Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression Ellen Foubert, Bram De Craene, and Geert Berx PMCID: PMC2917026 | Free in PMC on 2010/12/25 | Editorials At last, a predictive and prognostic marker for radiotherapy? Philip Coates, John Dewar, and Alastair M Thompson PMCID: PMC2917011 | Free in PMC on 2010/11/11 | What do we learn from HER2-positive breast cancer genomic profiles? Charles Theillet PMCID: PMC2917015 | Free in PMC on 2010/12/01 | Breast tumors: of mice and women Sean P McDermott and Max S Wicha PMCID: PMC2917013 | Free in PMC on 2010/11/27 | Just when you thought it was safe to go into the membrane: the growing complexities of extra-nuclear progesterone signaling Aritro Sen and Stephen R Hammes PMCID: PMC2917021 | Free in PMC on 2010/12/16 | Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition Catherine Van Poznak PMCID: PMC2917025 | Free in PMC on 2010/12/18 | Other Issues: Journal List
|
previous
|
next
|
latest
|
archive
|
